The Best Drug Stock for 2007 Revisited
120002
As we approach the halfway point in the calendar year, the results might shock you.
122895
Drug stocks across the board fell amid renewed safety concerns over a class of blockbuster drugs used to treat arthritis. Preprint articles published on the New England Journal of Medicine&#39;s Web site Wednesday
732317
The Dow Jones industrial average reached a milestone in Wall StreetÂs nearly seven-year recovery from corporate upheaval.
32315
Appleâs stock skyrocketed 135 percent in 2007, and its sleek retail gadget emporiums are a large part of that  success.
704135
The Fool's No. 2 top investor of 2007 discusses his predictions.
247318
The tried-and-true way to pick the market's best stocks.
125714
In 2007, the brokersâ customers did reasonably well. The brokers did not. How could that happen?
157379
The best stocks aren't always the most exciting businesses.
53001
Appleâs stock skyrocketed 135 percent in 2007, and its sleek retail gadget emporiums are a large part of that success.
602673
A Fool's prediction on the FDA's impending decision on approval.
459925
A stock for dividend investors' watch list.
182674
Is a new MS drug going to be a top seller or a bottom-dweller? Here's how to find out.
386840
Four tips to help find stocks that will beat the market in the year ahead.
108463
Pfizer is a good company, but a bad stock for 2008.
552579
Company earned 60 cents a share, down from 83 cents a year earlier; Vioxx linked to heart attacks. NEW YORK  - Merck &amp; Co.
258736
Here's how last year's stocks fared.
524656
The cardiovascular risk boogeyman is everywhere. First it struck Merck&#39;s (NYSE: MRK) Vioxx. Then Pfizer&#39;s (NYSE: PFE) Celebrex.